Jubilant Pharmova announced that its wholly owned subsidiary, Jubilant Pharma, Singapore has on 18 August 2022 redeemed the principal amount of US$200,000,000 6% Senior Notes Due in 2024 at a redemption price of 103% together with the accrued interest. After the said redemption, the Notes have been paid in full and no amount remains outstanding under the Notes. Further, Jubilant Pharma does not have any other securities listed on SGX. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.